BioDelivery Sciences (BDSI) Misses Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
BioDelivery Sciences Provides Corporate Update and Reports Third Quarter 2015 Financial Results
November 9, 2015 7:00 AM ESTRALEIGH, N.C., Nov. 9, 2015 /PRNewswire/ --Â BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today reported financial results for the third quarter ended September 30, 2015, and reviewed its most significant recent accomplishments and upcoming milestones.Â
Net revenue for BUNAVAIL increased 39% to $1.2 million compared to the second quarter. Net revenue for the nine months ended September 30, 2015, was $16.0 million, compared to $36.4 million in the same period of 2014. The nine month revenue for 2014 includes two milestone payments totaling $20 million for database locks for the... More
